A Zubel

Author PubWeight™ 5.87^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.	Ann Oncol	2011	4.95
2	Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group.	Ann Oncol	2008	1.02